Event Date/Time: Sep 27, 2009
Fibromyalgia is a chronic musculoskeletal pain condition that affects three to six million Americans of which 80% to 90% are women. This condition causes widespread muscular pain, fatigue, and tenderness. Gaps exist with regard to diagnosis and treatment contributing to clinical morbidity. This program educates providers about making an accurate diagnosis, particularly taking into account the high degree of co-morbidity that accompanies fibromyalgia. It also educates providers about newly approved pharmacologic agents they can combine with non-pharmacologic treatment modalities to improve the overall management of this debilitating condition.